Report Detail
Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size, Status and Forecast 2019-2025
- RnM3689020 |
- 22 August, 2019 |
- Global |
- 91 Pages |
- QYResearch |
- Pharma & Healthcare
Age-related macular degeneration is a bilateral ocular condition in which the central area of the retina, known as the macula, is affected.
Age-related macular degeneration is a progressive condition, and it is common among the geriatric population. The growing geriatric population is contributing to the rising incidence of age-related macular degeneration globally. As a result, there is a high demand for therapeutics to treat the condition. Pharmaceutical companies are leveraging this opportunity and are focusing on releasing drugs to treat age-related macular degeneration.
In 2018, the global Age-Related Macular Degeneration (AMD) Therapeutics market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Age-Related Macular Degeneration (AMD) Therapeutics status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Age-Related Macular Degeneration (AMD) Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study
Amgen Inc.
Bausch Health Companies, Inc.
F. Hoffmann-La Roche Ltd.
Novartis AG
Regeneron Pharmaceuticals Inc.
...
Market segment by Type, the product can be split into
Wet AMD
Dry AMD
Market segment by Application, split into
Hospital
Clinic
Research Institute
Other
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Age-Related Macular Degeneration (AMD) Therapeutics status, future forecast, growth opportunity, key market and key players.
To present the Age-Related Macular Degeneration (AMD) Therapeutics development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Age-Related Macular Degeneration (AMD) Therapeutics are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Wet AMD
- 1.4.3 Dry AMD
- 1.5 Market by Application
- 1.5.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Application (2019-2025)
- 1.5.2 Hospital
- 1.5.3 Clinic
- 1.5.4 Research Institute
- 1.5.5 Other
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Size
- 2.2 Age-Related Macular Degeneration (AMD) Therapeutics Growth Trends by Regions
- 2.2.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Regions (2019-2025)
- 2.2.2 Age-Related Macular Degeneration (AMD) Therapeutics Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Challenges
- 2.3.4 Porter’s Five Forces Analysis
3 Market Share by Key Players
- 3.1 Age-Related Macular Degeneration (AMD) Therapeutics Market Size by by Players
- 3.1.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue by by Players (2014-2019)
- 3.1.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Revenue Market Share by by Players (2014-2019)
- 3.1.3 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Concentration Ratio (CR5 and HHI)
- 3.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players Head office and Area Served
- 3.3 Key Players Age-Related Macular Degeneration (AMD) Therapeutics Product/Solution/Service
- 3.4 Date of Enter into Age-Related Macular Degeneration (AMD) Therapeutics Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type (2014-2019)
- 4.2 Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application (2014-2019)
5 North America
- 5.1 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2014-2019)
- 5.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in North America
- 5.3 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type
- 5.4 North America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application
6 Europe
- 6.1 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2014-2019)
- 6.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Europe
- 6.3 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type
- 6.4 Europe Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application
7 China
- 7.1 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2014-2019)
- 7.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in China
- 7.3 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type
- 7.4 China Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application
8 Japan
- 8.1 Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2014-2019)
- 8.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Japan
- 8.3 Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type
- 8.4 Japan Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2014-2019)
- 9.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Southeast Asia
- 9.3 Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type
- 9.4 Southeast Asia Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application
10 India
- 10.1 India Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2014-2019)
- 10.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in India
- 10.3 India Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type
- 10.4 India Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application
11 Central & South America
- 11.1 Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size (2014-2019)
- 11.2 Age-Related Macular Degeneration (AMD) Therapeutics Key Players in Central & South America
- 11.3 Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Type
- 11.4 Central & South America Age-Related Macular Degeneration (AMD) Therapeutics Market Size by Application
12 International Players Profiles
- 12.1 Amgen Inc.
- 12.1.1 Amgen Inc. Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Age-Related Macular Degeneration (AMD) Therapeutics Introduction
- 12.1.4 Amgen Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2014-2019))
- 12.1.5 Amgen Inc. Recent Development
- 12.2 Bausch Health Companies, Inc.
- 12.2.1 Bausch Health Companies, Inc. Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Age-Related Macular Degeneration (AMD) Therapeutics Introduction
- 12.2.4 Bausch Health Companies, Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2014-2019)
- 12.2.5 Bausch Health Companies, Inc. Recent Development
- 12.3 F. Hoffmann-La Roche Ltd.
- 12.3.1 F. Hoffmann-La Roche Ltd. Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Age-Related Macular Degeneration (AMD) Therapeutics Introduction
- 12.3.4 F. Hoffmann-La Roche Ltd. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2014-2019)
- 12.3.5 F. Hoffmann-La Roche Ltd. Recent Development
- 12.4 Novartis AG
- 12.4.1 Novartis AG Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Age-Related Macular Degeneration (AMD) Therapeutics Introduction
- 12.4.4 Novartis AG Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2014-2019)
- 12.4.5 Novartis AG Recent Development
- 12.5 Regeneron Pharmaceuticals Inc.
- 12.5.1 Regeneron Pharmaceuticals Inc. Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Age-Related Macular Degeneration (AMD) Therapeutics Introduction
- 12.5.4 Regeneron Pharmaceuticals Inc. Revenue in Age-Related Macular Degeneration (AMD) Therapeutics Business (2014-2019)
- 12.5.5 Regeneron Pharmaceuticals Inc. Recent Development
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Product (2019-2025)
- 13.2 Market Size Forecast by Application (2019-2025)
- 13.3 Market Size Forecast by Regions
- 13.4 North America
- 13.5 Europe
- 13.6 China
- 13.7 Japan
- 13.8 Southeast Asia
- 13.9 India
- 13.10 Central & South America
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 15.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Age-Related Macular Degeneration (AMD) Therapeutics. Industry analysis & Market Report on Age-Related Macular Degeneration (AMD) Therapeutics is a syndicated market report, published as Global Age-Related Macular Degeneration (AMD) Therapeutics Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Age-Related Macular Degeneration (AMD) Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
